Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Top Cited Papers
- 3 December 2009
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 361 (23) , 2209-2220
- https://doi.org/10.1056/nejmoa0908492
Abstract
The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.Keywords
This publication has 43 references indexed in Scilit:
- Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- HIV/AIDS preventive vaccine ‘prime-boost’ phase III trial: foundations and initial lessons learned from ThailandAIDS, 2006
- The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in AsiaSexually Transmitted Infections, 2004
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- HIV/AIDS Prevention in Thailand: Success and ChallengesScience, 1998
- Changes in Sexual Behavior and a Decline in HIV Infection among Young Men in ThailandNew England Journal of Medicine, 1996
- Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials NetworkJAMA, 1994
- Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseasesThe Lancet, 1994
- Risk factors for HIV infection among young adult men in northern ThailandPublished by American Medical Association (AMA) ,1993
- The epidemiology of HIV infection and AIDS in ThailandAIDS, 1991